|
|
H2015/CTD29701/577
|
OZICLIDE MR TABLETS
|
GLICLAZIDE MODIFIED RELEASE TABLETS
|
SUN PHARMA EAST AFRICA LTD
|
Registered
|
Details →
|
|
|
H2026/CTD9125/19768
|
OZINC-DT (PAEDIATRIC ZINC SULFATE TABLETS PH.INT. 20 MG)
|
ZINC SULFATE MONOHYDRATE USP
|
SAI PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2021/CTD7480/14378
|
OZITAS (OLANZEPINE INJECTION 10MG)
|
OLANZEPINE
|
ACCORD HEALTHCARE (K) LTD
|
Registered
|
Details →
|
|
|
15003
|
OZITAS 10MG
|
OLANZAPINE
|
ACCORD HEALTHCARE (K) LTD
|
Registered
|
Details →
|
|
|
15002
|
OZITAS 5MG
|
OLANZAPINE
|
ACCORD HEALTHCARE (K) LTD
|
Registered
|
Details →
|
|
|
H2016/CTD4106/898/R1
|
Olopat OD
|
Olopatadine Hydrochloride Ophthalmic Solution USP
|
Ajanta Pharma Limited
|
Retained
|
Details →
|
|
|
-
|
Ondansetron Tablets USP 4 mg
|
Ondansetron Hydrochloride Dihydrate Ph.Eur.
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
-
|
Ondansetron Tablets USP 8 mg
|
Ondansetron Hydrochloride Dihydrate Ph.Eur.
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
2197/R1
|
Otrivin Children Nasal Drops
|
Xylometazoline Hydrochloride
|
HALEON KENYA LIMITED
|
Retained
|
Details →
|
|
|
CTD4000/R1
|
Oxcin Ophthalmic Solution
|
Moxifloxacin
|
ATCO Laboratories Limited
|
Retained
|
Details →
|
|
|
H2018/CTD4000/455ER/R1
|
Oxcin Ophthalmic Solution
|
Moxifloxacin
|
ATCO Laboratories Limited
|
Retained
|
Details →
|
|
|
H2006/477
|
P M C BURN CREAM
|
SILVER SULFADIAZINE CREAM
|
SHALINA HEALTHCARE KENYA LIMITED
|
Registered
|
Details →
|
|
|
H2016/CTD4021/606
|
P SOLON
|
PREDNISOLONE 5MG
|
GALAXY PHARMACEUTICAL LIMITED
|
Registered
|
Details →
|
|
|
H2022/CTD10853/22549
|
P-ALAXIN DISPERSIBLE 20/160
|
DIHYDROARTEMISININ 20MG & PIPERAQUINE PHOSPHATE 160 MG DISPERSIBLE TABLETS
|
THERALIFE PHARMA LTD
|
Registered
|
Details →
|
|
|
H2022/CTD10852/22552
|
P-ALAXIN DISPERSIBLE 40/320
|
DIHYDROARTEMISININ 40MG & PIPERAQUINE PHOSPHATE 320 MG DISPERSIBLE TABLETS
|
THERALIFE PHARMA LTD
|
Registered
|
Details →
|
|
|
H2021/CTD6497/12728
|
P-ALAXIN DS
|
DIHYDROARTEMISININ AND PIPERAQUINE PHOSPHATE
|
THERALIFE PHARMA LTD
|
Registered
|
Details →
|
|
|
H2022/CTD10854/22806
|
P-ALAXIN DS 80/640
|
DIHYDROARTEMESININ 80 MG & PIPERAQUINE PHOSPATE 640 MGTABLETS
|
THERALIFE PHARMA LTD
|
Registered
|
Details →
|
|
|
H2008/18555/890
|
P-ALAXIN ORAL SUSPENSION
|
DIHYDROARTEMISININ PIPERAQUINE PHOSPHATE
|
THERALIFE PHARMA LTD
|
Registered
|
Details →
|
|
|
H2006/680
|
P-ALAXIN TABLET
|
DIHYDROARTEMISININ PIPERAQUINE PHOSPHATE
|
THERALIFE PHARMA LTD
|
Registered
|
Details →
|
|
|
H2008/18611/987
|
P-CLOX 500 MG INJECTION
|
AMPICILLIN & CLOXACILLIN SODIUM FOR INJECTION 500 MG
|
SYNER-MED PHARMACEUTICALS (K)LTD
|
Registered
|
Details →
|